The Food and Drug Administration is considering adding warning labels to antidepressants for women who are pregnant, despite ...

Last Monday, an expert panel convened by the U.S. Food and Drug Administration (FDA) to discuss the use of selective ...

Pregnancy presents a unique ethical dilemma. The unborn child cannot give consent, and damage sustained in the womb can ...

Members of an advisory panel have proposed adding warning labels to some medication about adverse maternal and fetal risks in ...

Leading medical experts have called for women to stop taking antidepressants during pregnancy over fears that they could ...

At a recent FDA panel on SSRIs in pregnancy, the chair suggested rising antidepressant use may be contributing to — not ...

An unusual FDA panel on antidepressant use during pregnancy elevated clinicians and researchers who are deeply skeptical of ...

As Covid cases begin to rise this summer, many may be wondering: What are my risks, and is it time to get another vaccine? As ...

The U.S. Food and Drug Administration is turning its attention to selective serotonin reuptake inhibitors, a class of antidepressant drugs long criticized by Health and Human Services ...

When the U.S. Food and Drug Administration (FDA) convened a public expert panel to review the use of selective serotonin ...